Natick, MA, United States of America

Christopher Blackburn

This inventor holds 15 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Millennium Pharmaceuticals Limited, Ore Pharmaceuticals Inc., Abbott Laboratories Corporation. Active years: 2005-2016.

USPTO Granted Patents = 15 

% Patents Active = 13.3

 

 

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 88(Granted Patents)


Company Filing History:


Years Active: 2005-2016

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Journey of Christopher Blackburn

Introduction: Christopher Blackburn, a talented inventor hailing from Natick, MA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Blackburn's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time, and a smart home system that enhances security through advanced AI technology.

Career Highlights: With a career spanning over two decades, Christopher Blackburn has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized with numerous awards and accolades.

Collaborations: Blackburn has collaborated with leading tech companies, research institutions, and universities to further his research and bring his inventions to life. His ability to work across disciplines has led to the successful development of groundbreaking technologies.

Conclusion: Christopher Blackburn's passion for innovation and dedication to pushing the boundaries of technology have solidified his position as a respected inventor in the industry. His relentless pursuit of excellence continues to inspire future generations of inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…